Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Axsome Therapeutics | 3,872 | 2024q2 | |||||||||
Atara Biotherapeutics | 969 | 2022 | |||||||||
Blend Labs | 1,102 | 2023q3 | |||||||||
WiSA Technologies | 11 | 2023q2 | |||||||||
Lucid Group | 4,580 | 2021 | |||||||||
Nektar Therapeutics | 95 | 2023q3 | |||||||||
Heron Therapeutics | 266 | 2023q3 | |||||||||
Karyopharm Therapeutics | 104 | 2022 | |||||||||
Allakos | 121 | 2023q3 | |||||||||
Recursion Pharmaceuticals | 1,614 | 2023 | |||||||||
IGM Biosciences | 827 | 2023q3 | |||||||||
Bellerophon Therapeutics | 0 | 2021 | |||||||||
Check-Cap | 182 | 2021 | |||||||||
Ultragenyx Pharmaceutical | 3,189 | 2023q3 | |||||||||
MediWound | 90 | 2023q1 | |||||||||
WiMi Hologram Cloud | 181 | 2023 | |||||||||
FTC Solar | 53 | 2023q3 | |||||||||
Allogene Therapeutics | 500 | 2023q3 | |||||||||
Virgin Galactic Holdings | 342 | 2023 | |||||||||
Blueprint Medicines | 5,358 | 2022 |